Filter
482
Featured
71
Language
Document type
129
87
60
57
47
36
21
13
9
8
7
6
1
1
Countries
38
20
18
13
11
11
10
9
9
8
8
6
5
4
4
4
4
4
4
4
3
3
3
3
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
126
19
9
8
7
2
1
Ethnic disparities in COVID-19 persist, with increased rates of infection, severe disease, and death among people from minority ethnic groups. COVID-19 vaccination rates also remain lowest in these communities compared with white people in the UK. Among people older than 18 years, the proportion who
...
mRNA technologies. What is their future and scope, and what are the challenges that countries might face in rolling them out? Hello and welcome to Science in5. I'm Vismita Gupta-Smith. We are talking to Dr.Soumya Swaminathan today. Soumya, talk to us about mRNA technologies. What is the future?
This report’s central premise is that diagnostics and therapeutics, and associated test to treat strategies, are fundamental components of the pandemic response, both for COVID-19 and for future health threats. Two years into the COVID-19 pandemic, this report reflects on the main challenges and k
...
L’ensemble du personnel de santé qui participe au déploiement et à la mise en œuvre de la vaccination contre la COVID-19 doit avoir les connaissances et les compétences requises pour garantir une administration sûre et efficace du vaccin contre la COVID-19. Ce cours de formation fournit des
...
يحتاج العاملون الصحيون الذين يشاركون في نشر وتنفيذ التطعيم ضد كوفيد-19 إلى معرفة خاصة بكل لقاح لضمان تقديم اللقاحات بشكل آمن وفعال. يوفر هذا التدريب معلومات أساسية ح
...
Declarations of interests were collected from all external contributors and assessed for any conflicts of interest. Summaries of the reported interests can be found on the SAGE meeting website and SAGE Covid-19 Working Group webpage. This guidance should be considered along with the broader COVID-
...
31 Oct 2022 his plan outlines how the ACT-Accelerator will support countries as the world transitions to long-term COVID-19 control.
Recognizing the evolving nature of the COVID-19 virus and pandemic, the plan outlines changes to ACT-A’s set-up and ways of working, to ensure countries co
...
Despite high regional demand for vaccines valued at over US$ 1 billion annually, Africa’s vaccine industry provides only 0.1% of global supply. Vaccine inequity and hoarding at the start of the pandemic, which resulted in delays in obtaining COVID-19 doses, stimulated new resolve to address future
...
The report aims to capture lessons from the COVID-19 pandemic and to highlight the opportunity for more ambitious global action: expanding sustainable access to vaccines for all towards
the Immunization Agenda 2030 and pandemic prevention, preparedness and response efforts. The report is organized
...
La lutte contre l’épidémie de Covid-19 nous montre de manière cinglante que, sur le terrain de l’action en santé publique, les logiques de promotion de la santé sont bel et bien minoritaires. Pendant cette période de crise, la décision
politique et sanitaire se base largement sur un mod
...
This document outlines the working structure and guiding principles for collaboration of COVAX, the Vaccines pillar of the Access to COVID-19 Tools Accelerator (ACT-A). The working structure of COVAX continues to adapt to emerging needs and the changing trajectory of the pandemic. Some components of
...
Here are resources to help accredited continuing education (CE) providers develop and deliver education about the COVID-19 vaccines. If you have any questions about accreditation requirements or any aspect of accredited education related to these vaccines
Ce modèle de plan de communication est conçu pour donner aux pays une idée générale des activités de communication à considérer lorsqu'ils préparent l'introduction des vaccins contre la COVID-19. Le tableau ci-dessous doit être complété, avec un plan de communication narratif fournissant
...
Mythes & COVID-19 Vaccins
recommended
MEDBOX Dossier no. 16. 28 Sept 2021.
De nombreuses études ont montré l'efficacité de la vaccination contre le COVID-19 et le fait qu'elle protège contre les maladies graves.
maladie grave. Un taux de vaccination élevé est nécessaire pour combattre la pandémie dans le monde entier. En raiso
...
Empfehlungen des Robert Koch-Instituts für Alten- und Pflegeeinrichtungen und Einrichtungen für Menschen mit Beeinträchtigungen und Behinderungen und für den öffentlichen Gesundheitsdienst
Stand 7.4.2021
Interim Guidance, 12 July 2021; This tool was developed to assess present and surge capacities for the treatment of COVID-19 in health facilities. It allows health facilities to assess the availability and status of stockout of critical COVID-19 medicines, equipment and supplies on site and to ident
...
This article is part four in a series of explainers on vaccine development and distribution
Available in different languages
This article is part two in a series of explainers on vaccine development and distribution. Part one focused on how vaccines work to protect our bodies from disease-carrying germs. This article focuses on the ingredients in a vaccine and the three clinical trial phases. Part three outlines the nex
...
